for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Acer Announces Acer-001 For Urea Cycle Disorders Trial Shows Bioequivalence To Buphenyl

Feb 24 (Reuters) - Acer Inc:

* ACER THERAPEUTICS ANNOUNCES ACER-001 FOR UREA CYCLE DISORDERS TRIAL SHOWS BIOEQUIVALENCE TO BUPHENYL® Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up